HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

naloxonazine

binds irreversibly to opiate receptor sites; structure given in first source
Also Known As:
Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, ((5alpha)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene)hydrazone, (5alpha)-
Networked: 29 relevant articles (1 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Suzuki, Tsutomu: 2 articles (10/2013 - 09/2013)
2. Mori, Tomohisa: 2 articles (10/2013 - 09/2013)
3. Shibasaki, Masahiro: 2 articles (10/2013 - 09/2013)
4. Felippotti, Tatiana Tocchini: 2 articles (02/2012 - 12/2011)
5. Coimbra, Norberto Cysne: 2 articles (02/2012 - 12/2011)
6. Wang, Erika: 1 article (10/2013)
7. Yoshizawa, Kazumi: 1 article (10/2013)
8. Hasegawa, Minami: 1 article (10/2013)
9. Masukawa, Daiki: 1 article (10/2013)
10. Shibasaki, Yumiko: 1 article (10/2013)

Related Diseases

1. Seizures (Seizure)
2. Hyperphagia
3. Epilepsy (Aura)
4. Heart Failure
5. Fistula

Related Drugs and Biologics

1. Dendrimers (Dendrons)
2. Pentylenetetrazole (Metrazol)
3. Opioid Receptors (Opioid Receptor)
4. Naloxone (Narcan)
5. beta-funaltrexamine
6. N-methylnaloxone
7. Morphine (MS Contin)
8. Naltrexone (ReVia)
9. mu Opioid Receptors (mu Opioid Receptor)
10. Enkephalins

Related Therapies and Procedures

1. Analgesia
2. Induced Hyperthermia (Thermotherapy)